Skip to main content

SBIRT and MAT Provider Toolkit

We're committed to working with you to improve outcomes for members managing substance use disorders. This go-to toolkit offers guidance, referral processes and practical clinical tools to integrate SBIRT (screening, brief intervention and referral to treatment) and MAT (medication-assisted treatment) into your everyday practice.

 

Download the SBIRT Provider Toolkit (PDF)

SBIRT Tools and Implementation

Find answers to common questions, billing and coding and other SBIRT information.

  • What is SBIRT? 
     

    SBIRT stands for screening, brief intervention and referral to treatment. It’s an evidence-based, preventive approach that health care providers use to identify and address substance use disorders before they escalate. 

     

    Who qualifies for SBIRT screening?  
     

    All patients can benefit from SBIRT, especially those in primary care, obstetrics and gynecology (ob/gyn), emergency or behavioral health settings. We recommend that OB/GYN providers include SBIRT as part of routine prenatal care. 

     

    What approved tools are recommended for screening? 
     

    Here’s a list of tools:
     

     

    How long does SBIRT take to implement? 

    Screening takes only a few minutes. Brief interventions range from 5 to 15 minutes. Referral coordination can be streamlined using partner networks like Brave Health or Groups Recover Together. 

     

    What should I do if a member screens positive? 
     

    Here are a few steps you can take:
     

    • Engage the member using motivational interviewing techniques 

    • Offer brief intervention with empathetic, nonjudgmental discussion 

    • Refer to MAT and/or behavioral health services 

    • Document in electronic medical record (EMR) and use referral pathways 

  • Check the billing and coding reference chart below. Keep in mind that provider documentation must support time spent and include risk assessment, intervention details and referrals.   
     

    Providers authorized to bill for SBIRT include:
     

    • Physicians (MD/DO)

    • Physician assistants (PAs)

    • Advanced practice registered nurses (APRNs) 

    Code

    Code Type

    Description

    Typical use case

    99408 

    CPT 

    Alcohol and/or substance abuse structured screening and brief intervention, 15 to 30 minutes 

    Time-based intervention involving motivational interviewing and education. This may follow a positive screening. 

    99409 

    CPT 

    Alcohol and/or substance abuse structured screening and brief intervention, greater than 30 minutes 

    Extended intervention for patients needing more in-depth discussion and behavioral counseling. 

    H0049 

    HCPCS 

    Alcohol and/or drug screening 

    Brief screening with a validated tool conducted in primary or behavioral health settings. 

    H0050 

    HCPCS 

    Alcohol and/or drug services, brief intervention per 15 minutes 

    Used in settings such as outpatient counseling or integrated behavioral health care. 

    G0396 

    HCPCS 

    Alcohol and/or substance abuse structured assessment and brief intervention, 15 to 30 minutes 

    Similar to 99408 but billed in federally funded or Federally Qualified Health Center (FQHC) environments. 

    G0397 

    HCPCS 

    Alcohol and/or substance abuse structured assessment and brief intervention, greater than 30 minutes 

    Similar to 99409 but billed in federally funded or FQHC environments. 

    Code

    99408 

    Code Type

    CPT 

    Description

    Alcohol and/or substance abuse structured screening and brief intervention, 15 to 30 minutes 

    Typical use case

    Time-based intervention involving motivational interviewing and education. This may follow a positive screening. 

    Code

    99409 

    Code Type

    CPT 

    Description

    Alcohol and/or substance abuse structured screening and brief intervention, greater than 30 minutes 

    Typical use case

    Extended intervention for patients needing more in-depth discussion and behavioral counseling. 

    Code

    H0049 

    Code Type

    HCPCS 

    Description

    Alcohol and/or drug screening 

    Typical use case

    Brief screening with a validated tool conducted in primary or behavioral health settings. 

    Code

    H0050 

    Code Type

    HCPCS 

    Description

    Alcohol and/or drug services, brief intervention per 15 minutes 

    Typical use case

    Used in settings such as outpatient counseling or integrated behavioral health care. 

    Code

    G0396 

    Code Type

    HCPCS 

    Description

    Alcohol and/or substance abuse structured assessment and brief intervention, 15 to 30 minutes 

    Typical use case

    Similar to 99408 but billed in federally funded or Federally Qualified Health Center (FQHC) environments. 

    Code

    G0397 

    Code Type

    HCPCS 

    Description

    Alcohol and/or substance abuse structured assessment and brief intervention, greater than 30 minutes 

    Typical use case

    Similar to 99409 but billed in federally funded or FQHC environments. 

MAT Tools and Implementation

Find answers to common questions, eligibility criteria and information about how to become a MAT prescriber.

  • What is MAT? 
     

    Medication-assisted treatment (MAT) is an evidence-based approach that combines FDA-approved medications with counseling and behavioral therapies to treat opioid use disorder (OUD). MAT helps patients stabilize opioid use, reduces overdose risk, and improves overall health outcomes.  

    For pregnant individuals, MAT supports healthy pregnancy outcomes, reduces preterm birth risk, and enhances maternal and neonatal well-being. Abrupt withdrawal or detoxification during pregnancy is strongly discouraged. 

     

    Who can receive MAT? 
     

    • General population: Anyone diagnosed with OUD can benefit from MAT. 

    • Pregnant patients: MAT is recommended as part of routine prenatal care to stabilize opioid use, improve prenatal engagement, and support neonatal health. 

     

    What are the recommended medications for opioid use disorder? 

    Medication 

    Preferred use 

    Notes 

    Buprenorphine 

    First-line for most patients 

    May reduce neonatal abstinence syndrome (NAS) severity compared to methadone. 

    Methadone 

    Alternative if buprenorphine not effective or accessible 

    Typically dispensed through certified opioid treatment programs (OTPs); daily clinic visits may be required. 

    Naltrexone 

    Not recommended to initiate during pregnancy 

    May continue only if patient is stable and risk of relapse is high. 

    Medication 

    Buprenorphine 

    Preferred use 

    First-line for most patients 

    Notes 

    May reduce neonatal abstinence syndrome (NAS) severity compared to methadone. 

    Medication 

    Methadone 

    Preferred use 

    Alternative if buprenorphine not effective or accessible 

    Notes 

    Typically dispensed through certified opioid treatment programs (OTPs); daily clinic visits may be required. 

    Medication 

    Naltrexone 

    Preferred use 

    Not recommended to initiate during pregnancy 

    Notes 

    May continue only if patient is stable and risk of relapse is high. 

  • We encourage eligible providers to offer medication-assisted treatment (MAT) using buprenorphine to support Medicaid members with opioid use disorder. 

     

    Who can prescribe buprenorphine? 
     

    Licensed health care professionals in Florida who hold a DEA (U.S. Drug Enforcement Administration) registration with Schedule III authority can prescribe buprenorphine for opioid use disorder. This includes: 

    • Physicians (MD or DO) 

    • Nurse practitioners (NPs) 

    • Physician assistants (PAs) 

    • Clinical nurse specialists (CNS), certified nurse midwives (CNMs) and certified registered nurse

    • Anesthetists (CRNAs) (depending on scope of practice)  

  • The DATA 2000 “X-waiver” requirement was removed in 2023. A separate waiver is no longer needed. 

     

    Follow these steps to get started:  
     

    1. Confirm state licensure  

    You must hold an active Florida license to practice and prescribe controlled substances. 

     

    2. Apply for DEA registration 

    Submit DEA Form 224 online at the DEA Diversion Control Division and select Schedules II, III, IV, and V to include buprenorphine (Schedule III).  

     

    3. Confirm Aetna Better Health® of Florida network alignment 

    You’ll need to confirm that your CAQH credentialing profile reflects MAT services. And you’ll need to update your practice listing so you’re searchable for MAT.   

     

    If you are not already in network, join our provider network and confirm that your taxonomy codes are accurately submitted to ensure claims are processed. 

     

     Quick tips about coverage and prior authorization (PA) 
     

    • Buprenorphine-containing products are covered for Medicaid members.  

    • Automatic PA applies to most buprenorphine prescriptions. 

Interested in becoming a MAT prescriber? 

Becoming a MAT prescriber helps reduce overdose risk and improves long-term recovery outcomes. If you want to learn more about becoming a MAT prescriber, contact us

Training, contacts and other resources

Expand your knowledge with trainings, connect with support partners and find other resources and information for both SBIRT and MAT.

Questions?

Email Yentl Lega, your SBIRT/MAT liaison. You can also email us or call us at 1-800-441-5501 (TTY: 711).

Also of interest: